Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Restless Genital Syndrome

ReGS - Small Fiber Sensory Neuropathy of the Genital Nerves

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not FDA-regulated; no approved therapy

Reference only. Not medical advice.

What can go wrong

Under-recognition leads to inappropriate psychiatric labeling. Evidence is limited to small case series; there is no controlled treatment data. Any neuromodulatory or pharmacologic intervention requires neurological evaluation.

This is something to take to a clinician. The Atlas can tell you what is known about restless genital syndrome in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Restless genital syndrome combines the diagnostic criteria of PGAD with restless legs syndrome and/or overactive bladder. Waldinger and colleagues reported the first male cases and provided evidence that ReGS reflects small fiber sensory neuropathy (SFSN) of the pudendal nerve and its genital end branches. Sensory testing typically reveals static mechanical hyperesthesia in the dorsal nerve distribution.

The genital analogue of restless legs - and a small-fiber neuropathy signature.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Neurological framing of unwanted genital arousal
  • Screening for concurrent restless legs and overactive bladder

How it is supposed to work

Typical sensory abnormalities of the genital end branches of the pudendal nerve, demonstrable in both sexes, point to small fiber sensory neuropathy as a common cause. The overlap with restless legs syndrome suggests a shared dopaminergic and small-fiber substrate rather than a purely psychogenic origin.

What people get wrong

  • Often saidRestless genital syndrome is purely psychological

    ActuallyCase-series evidence links it to small fiber sensory neuropathy of the pudendal nerve, arguing for an organic peripheral-nerve basis in many patients.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Core triad
PGAD-type arousal + RLS and/or OAB
Nerve implicated
Pudendal / dorsal nerve
Signature
Small fiber sensory neuropathy

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Restless Genital Syndrome. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Waldinger et al., stronger evidence for SFSN in ReGS - two male cases (PubMed 20955316)2011

    Documented ReGS in males and linked it to small fiber sensory neuropathy

  • Static mechanical hyperesthesia and neuropathy of the dorsal nerve (PubMed 19732313)2009

    Identified a reproducible sensory-testing abnormality in ReGS

  • TENS in ReGS (role of A-delta and C fibers)2010s

    Transcutaneous electrical nerve stimulation reduced symptoms in reported cases